Literature DB >> 18007032

Structure and activity of Yersinia pestis 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase as a novel target for the development of antiplague therapeutics.

Jaroslaw Blaszczyk1, Yue Li, Scott Cherry, Jerry Alexandratos, Yan Wu, Gary Shaw, Joseph E Tropea, David S Waugh, Honggao Yan, Xinhua Ji.   

Abstract

6-Hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) is a key enzyme in the folate-biosynthetic pathway and is essential for microorganisms but absent from mammals. HPPK catalyzes Mg(2+)-dependent pyrophosphoryl transfer from ATP to 6-hydroxymethyl-7,8-dihydropterin (HP). Previously, three-dimensional structures of Escherichia coli HPPK (EcHPPK) have been determined at almost every stage of its catalytic cycle and the reaction mechanism has been established. Here, the crystal structure of Yersinia pestis HPPK (YpHPPK) in complex with HP and an ATP analog is presented together with thermodynamic and kinetic characterizations. The two HPPK molecules differ significantly in a helix-loop area (alpha2-Lp3). YpHPPK has lower affinities than EcHPPK for both nucleotides and HP, but its rate constants for the mechanistic steps of both chemical transformation and product release are comparable with those of EcHPPK. Y. pestis, which causes plague, is a category A select agent according to the Centers for Disease Control and Prevention (CDC). Therefore, these structural and biochemical data are valuable for the design of novel medical countermeasures against plague.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18007032     DOI: 10.1107/S0907444907047452

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  9 in total

1.  The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.

Authors:  Mi-Kyung Yun; Daniel Hoagland; Gyanendra Kumar; M Brett Waddell; Charles O Rock; Richard E Lee; Stephen W White
Journal:  Bioorg Med Chem       Date:  2014-02-25       Impact factor: 3.641

2.  Virtual screening and in vitro validation identifies the first reported inhibitors of Salmonella enterica HPPK.

Authors:  Ronel Müller; Tiaan M Gerwel; Magambo Phillip Kimuda; Özlem Tastan Bishop; Clinton G L Veale; Heinrich C Hoppe
Journal:  RSC Med Chem       Date:  2021-08-23

3.  Crystal structure of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase•dihydropteroate synthase bifunctional enzyme from Francisella tularensis.

Authors:  Charles W Pemble; Perdeep K Mehta; Smriti Mehra; Zhenmei Li; Amanda Nourse; Richard E Lee; Stephen W White
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

4.  Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery.

Authors:  Hyun Uk Kim; Soo Young Kim; Haeyoung Jeong; Tae Yong Kim; Jae Jong Kim; Hyon E Choy; Kyu Yang Yi; Joon Haeng Rhee; Sang Yup Lee
Journal:  Mol Syst Biol       Date:  2011-01-18       Impact factor: 11.429

5.  Structure of S. aureus HPPK and the discovery of a new substrate site inhibitor.

Authors:  Sandeep Chhabra; Olan Dolezal; Brett M Collins; Janet Newman; Jamie S Simpson; Ian G Macreadie; Ross Fernley; Thomas S Peat; James D Swarbrick
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

6.  Proteomics-based refinement of Deinococcus deserti genome annotation reveals an unwonted use of non-canonical translation initiation codons.

Authors:  Mathieu Baudet; Philippe Ortet; Jean-Charles Gaillard; Bernard Fernandez; Philippe Guérin; Christine Enjalbal; Gilles Subra; Arjan de Groot; Mohamed Barakat; Alain Dedieu; Jean Armengaud
Journal:  Mol Cell Proteomics       Date:  2009-10-29       Impact factor: 5.911

7.  Structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase-dihydropteroate synthase from Plasmodium vivax sheds light on drug resistance.

Authors:  Manickam Yogavel; Joanne E Nettleship; Akansha Sharma; Karl Harlos; Abhishek Jamwal; Rini Chaturvedi; Manmohan Sharma; Vitul Jain; Jyoti Chhibber-Goel; Amit Sharma
Journal:  J Biol Chem       Date:  2018-08-13       Impact factor: 5.157

8.  Exploring the chemical space around 8-mercaptoguanine as a route to new inhibitors of the folate biosynthesis enzyme HPPK.

Authors:  Sandeep Chhabra; Nicholas Barlow; Olan Dolezal; Meghan K Hattarki; Janet Newman; Thomas S Peat; Bim Graham; James D Swarbrick
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

Review 9.  Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery.

Authors:  Christina R Bourne
Journal:  Antibiotics (Basel)       Date:  2014-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.